Related Experiment Video
Updated: Jul 20, 2026

An Improved Method to Isolate Mitochondrial Contact Sites
Published on: June 16, 2023
No association of chromatin-modifying protein 2B with sporadic frontotemporal dementia
Axel Schumacher1, Patricia Friedrich, Janine Diehl-Schmid
1Laboratory of Neurochemistry and Neurogenetics, Department of Psychiatry and Psychotherapy, Munich, Germany.
Abstract:
Mutations of the chromatin modifying protein 2B gene (CHMP2B) were identified, in a Danish pedigree, to cause familial frontotemporal dementia (FTD). To explore the possible genetic contribution of common CHMP2B variants in sporadic FTD, we analyzed 14 single nucleotide polymorphisms covering the entire genomic region of CHMP2B. After adjustment for multiple testing single marker and haplotype analysis revealed no significant association with sporadic FTD. Thus, we conclude that CHMP2B can be excluded as a susceptibility gene conferring risk to sporadic forms of FTD.
Related Concept Videos
Spreading of Chromatin Modifications
Writers
The writer is an enzyme that can...
Alzheimer Disease ll: Pathophysiology
Histone Variants at the Centromere
Duplication of Chromatin Structure
The basic unit of the chromatin is the nucleosome, consisting of DNA wrapped around octameric histone proteins and short stretches of linker DNA separating individual nucleosomes. The histone proteins within the nucleosome have their...
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease l: Introduction
